1. Home
  2. PESI vs STRO Comparison

PESI vs STRO Comparison

Compare PESI & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

HOLD

Current Price

$15.60

Market Cap

370.3M

Sector

Industrials

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$16.16

Market Cap

332.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PESI
STRO
Founded
1990
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
370.3M
332.8M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
PESI
STRO
Price
$15.60
$16.16
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $31.33
AVG Volume (30 Days)
261.8K
★ 288.8K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 43.61
N/A
EPS
★ N/A
N/A
Revenue
$642,000.00
★ $38,419,000.00
Revenue This Year
$34.62
N/A
Revenue Next Year
$77.02
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$8.58
$0.72
52 Week High
$21.32
$43.85

Technical Indicators

Market Signals
Indicator
PESI
STRO
Relative Strength Index (RSI) 34.69 30.44
Support Level $14.18 $14.81
Resistance Level $16.25 $17.33
Average True Range (ATR) 0.82 1.05
MACD -0.38 0.09
Stochastic Oscillator 13.32 22.32

Price Performance

Historical Comparison
PESI
STRO

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: